Orviva

Learn · Variants · TPMT

rs1800460 TPMT

TPMT*3B homozygous. Deficient TPMT activity; thiopurines (azathioprine, mercaptopurine) require major dose reduction.

Curated · human-reviewed Drug response · Risk / effect allele: A · dbSNP

What is rs1800460?

rs1800460 is a single-nucleotide polymorphism (SNP) in the TPMT gene (Thiopurine S-methyltransferase). Each person carries two copies, one from each parent, so a result is reported as a pair of letters such as AA. The table below describes what studies associate with each genotype; the association is statistical, across populations, and is not a diagnosis.

What does each rs1800460 genotype mean?

GenotypeAssociationWhat the evidence saysConfidence
AAincreasedTPMT*3B homozygous. Deficient TPMT activity; thiopurines (azathioprine, mercaptopurine) require major dose reduction.93%
GA / AGincreasedTPMT*3B carrier. Intermediate TPMT activity; moderate dose reduction needed.90%
GGtypicalNormal TPMT activity. Standard thiopurine dosing.93%

How common is the A allele of rs1800460?

Minor-allele frequency by population (gnomAD / 1000 Genomes):

European5.0%
East Asian1.0%
African1.0%
South Asian2.0%
Admixed American3.0%
Global3.0%

Which drugs have annotations for rs1800460?

PharmGKB clinical annotations (level 1A is the strongest evidence, 4 the weakest):

DrugAnnotation typeEvidence level
cisplatinToxicity3

Is rs1800460 on 23andMe and AncestryDNA chips?

Yes — it is genotyped directly on 23andMe V3, 23andMe V4, 23andMe V5, AncestryDNA V1, AncestryDNA V2. Orviva reads it from a raw-data export without imputation.

Sources

Genetic associations describe risk across populations, not a diagnosis for any one person. Most variants shift risk modestly and act alongside lifestyle, environment and other genes. Consumer DNA chips do not read every position and can be wrong at any single one. For general education only; talk to a clinician or genetic counsellor before acting on anything here, and never change a prescribed medicine without your prescriber.